{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:09:22Z","timestamp":1787004562103,"version":"build-2736575974"},"reference-count":27,"publisher":"Wiley","issue":"3-4","license":[{"start":{"date-parts":[[2004,4,8]],"date-time":"2004-04-08T00:00:00Z","timestamp":1081382400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    In the present study, the authors administered 100\u2003mg itraconazole (ITCZ) twice daily for a period of 1\u2003week to six patients with hyperkeratotic type tinea pedis, and examined its efficacy, safety profile, and usefulness. ITCZ concentration in stratum corneum was also measured to examine the mobility of the drug into the affected site of planta pedis. ITCZ concentration in the stratum corneum of the affected part was first detected at 1\u2003week after the completion of administration, gradually increased over time, and peaked at 3\u2003weeks, with the sum of ITCZ and hydroxyitraconazole (OH\u2010ITCZ) amounting to 163.7\u2003ng\u2003g\n                    <jats:sup>\u22121<\/jats:sup>\n                    on a average. It then gradually decreased to a total sum of 10.3\u2003ng\u2003g\n                    <jats:sup>\u22121<\/jats:sup>\n                    on average at 8\u2003weeks following the completion of administration. When compared with the geometric mean minimum inhibitory concentration (MIC) of ITCZ against fresh clinical isolates of dermatophytes (\n                    <jats:italic>Trichophyton rubrum<\/jats:italic>\n                    ) (0.06\u2003\n                    <jats:italic>\u03bc<\/jats:italic>\n                    g\u2003ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    ), the stratum corneum ITCZ concentration in this study was 2.1\u2010fold of the geometric mean MIC at 2\u2003weeks following the completion of administration, and 2.4\u2010fold at 4\u2003weeks. Although ITCZ does not produce therapeutic effectiveness (fungistasis) during the period of administration, it starts appearing at 2\u2003weeks after the completion of administration, and after it peaks out at 3\u20134\u2003weeks, clinical symptoms started improving. These results suggest that satisfying effects can be achieved in a short\u2010term oral ITCZ at a dose of 100\u2003mg twice daily for a period of 1\u2003week in cases of hyperkeratotic type tinea pedis.\n                  <\/jats:p>","DOI":"10.1046\/j.1439-0507.2003.00952.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T06:49:00Z","timestamp":1104130140000},"page":"104-114","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis"],"prefix":"10.1111","volume":"47","author":[{"given":"K","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,8]]},"reference":[{"key":"e_1_2_40_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70037-7"},{"key":"e_1_2_40_3_2","first-page":"423","article-title":"Clinical studies on a novel oral antifungal agent itraconazole against hyperkeratotic type tinea manuum, tinea pedis, tinea capitis, kerion celsi, and sycosis trichophytica","volume":"25","author":"Dermatology Study Group on Itraconazole","year":"1991","journal-title":"Clin Rep"},{"key":"e_1_2_40_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1997.tb00219.x"},{"key":"e_1_2_40_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00317.x"},{"key":"e_1_2_40_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00403.x"},{"key":"e_1_2_40_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2000.00578.x"},{"key":"e_1_2_40_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2000.00560.x"},{"key":"e_1_2_40_9_2","first-page":"263","article-title":"Clinical use of tioconazole cream against hyperkeratotic type tinea pedis","volume":"22","author":"Umezawa A","year":"1985","journal-title":"Diagn New Drugs"},{"key":"e_1_2_40_10_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.51.1207"},{"key":"e_1_2_40_11_2","first-page":"1939","article-title":"Treatment of hyperkeratotic type tinea pedis","volume":"37","author":"Tanuma H","year":"1995","journal-title":"Jpn J Clin Dermatol"},{"key":"e_1_2_40_12_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.58.668"},{"key":"e_1_2_40_13_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.58.1033"},{"key":"e_1_2_40_14_2","first-page":"180","article-title":"Pulse therapy with one\u2010week itraconazole monthly for three or four months in the treatment of onychomycosis","volume":"56","author":"Doncker P","year":"1995","journal-title":"Cutis"},{"key":"e_1_2_40_15_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.1996.03890250044008","article-title":"Antifungal pulse therapy for onychomycosis. A pharmacokinetics and pharmacodynamic investigation of monthly cycles of 1\u2010week pulse therapy with itraconazole","volume":"132","author":"Doncker P","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_40_16_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.58.887"},{"key":"e_1_2_40_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1999.tb03517.x"},{"key":"e_1_2_40_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00264.x"},{"key":"e_1_2_40_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02296.x"},{"key":"e_1_2_40_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb03920.x"},{"key":"e_1_2_40_21_2","first-page":"138","article-title":"External and internal therapy for hyperkeratotic type tinea pedis","volume":"68","author":"Tanuma H.","year":"2001","journal-title":"Jpn J Clin Dermatol"},{"key":"e_1_2_40_22_2","first-page":"110","volume-title":"Proceedings of the 7th Dermatological Mycology Club Regular Meeting","author":"Tanuma H","year":"2001"},{"key":"e_1_2_40_23_2","first-page":"S75","article-title":"Usefulness of short\u2010term administration of itraconazole as a treatment of hyperkeratotic type tinea pedis","volume":"55","author":"Tanuma H","year":"2001","journal-title":"Jpn J Clin Dermatol"},{"key":"e_1_2_40_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90527-A"},{"key":"e_1_2_40_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03186.x"},{"key":"e_1_2_40_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81838-5"},{"key":"e_1_2_40_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.3.371"},{"key":"e_1_2_40_28_2","first-page":"571","article-title":"In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses","volume":"44","author":"Uchida K","year":"1991","journal-title":"Jpn J Antibiot"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0507.2003.00952.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0507.2003.00952.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:00:54Z","timestamp":1693461654000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0507.2003.00952.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":27,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1046\/j.1439-0507.2003.00952.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0507.2003.00952.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}